Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.
Kiertiburanakul S, Boettiger D, Ng OT, Van Kinh N, Merati TP, Avihingsanon A, Wong WW, Lee MP, Chaiwarith R, Kamarulzaman A, Kantipong P, Zhang F, Choi JY, Kumarasamy N, Ditangco R, Cuong DD, Oka S, Sim BLH, Ratanasuwan W, Ly PS, Yunihastuti E, Pujari S, Ross JL, Law M, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD).
Kiertiburanakul S, et al. Among authors: boettiger d.
AIDS Res Ther. 2017 May 5;14:27. doi: 10.1186/s12981-017-0151-1. eCollection 2017.
AIDS Res Ther. 2017.
PMID: 28484509
Free PMC article.